Financial results - HELIANTHUS PHARM SRL

Financial Summary - Helianthus Pharm Srl
Unique identification code: 16359958
Registration number: J22/819/2004
Nace: 4773
Sales - Ron
576.057
Net Profit - Ron
-126.651
Employee
9
The most important financial indicators for the company Helianthus Pharm Srl - Unique Identification Number 16359958: sales in 2023 was 576.057 euro, registering a net profit of -126.651 euro and having an average number of 9 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Helianthus Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 569.273 598.587 536.582 574.621 613.781 730.954 811.883 685.631 613.860 576.057
Total Income - EUR 596.215 621.418 565.048 592.808 656.415 751.783 833.112 732.413 633.434 589.407
Total Expenses - EUR 551.039 506.134 522.023 569.441 645.420 734.706 769.875 640.640 609.398 712.219
Gross Profit/Loss - EUR 45.175 115.283 43.025 23.367 10.995 17.077 63.238 91.773 24.036 -122.812
Net Profit/Loss - EUR 37.305 96.809 35.416 18.269 4.445 9.559 57.058 84.595 17.828 -126.651
Employees 14 15 16 15 15 13 13 11 9 9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -5.9%, from 613.860 euro in the year 2022, to 576.057 euro in 2023. The Net Profit decreased by -17.774 euro, from 17.828 euro in 2022, to 0 in the last year.

Check the financial reports for the company - Helianthus Pharm Srl

Rating financiar

Financial Rating -
Helianthus Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Helianthus Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Helianthus Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Helianthus Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Helianthus Pharm Srl - CUI 16359958

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 17.515 16.712 14.628 15.218 30.019 31.023 25.344 37.411 57.550 41.431
Current Assets 266.482 352.970 172.751 194.915 182.564 222.824 297.552 266.186 215.996 120.016
Inventories -20.720 36.023 60.167 77.478 61.261 13.882 12.531 39.247 76.731 36.450
Receivables 104.052 64.660 13.900 86.536 116.589 95.313 183.556 89.027 136.099 70.218
Cash 183.151 252.286 98.684 30.901 4.713 113.630 101.465 137.911 3.167 13.348
Shareholders Funds 101.531 199.187 35.597 18.446 22.552 31.675 57.225 76.640 17.992 -126.487
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 182.467 170.494 151.782 191.687 190.031 222.173 265.836 227.119 255.554 288.156
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 120.016 euro in 2023 which includes Inventories of 36.450 euro, Receivables of 70.218 euro and cash availability of 13.348 euro.
The company's Equity was valued at -126.487 euro, while total Liabilities amounted to 288.156 euro. Equity decreased by -144.425 euro, from 17.992 euro in 2022, to -126.487 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Helianthus Pharm Srl

Comments - Helianthus Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.